The Journal of Immunology, Vol 145, Issue 8 2554-2560, Copyright © 1990 by American Association of Immunologists

ARTICLES

An idiotype shared by monoclonal antibodies to different peptides of human myelin basic protein

SR Zhou and JN Whitaker
Department of Neurology, University of Alabama, Birmingham.

A mAb of the IgG1/kappa isotype was raised against human myelin basic protein (MBP) peptide acetyl 1-9. This mAb, termed F23, reacted with human MBP and human MBP peptides acetyl 1-9, 1-14, and 1-44, but not with MBP peptides 10-19, 80-89, or 45-89. According to the guidelines of the molecular recognition theory, a complementary peptide to human MBP peptide 1-9 was synthesized and used to raise murine mAb with anti- Id activity. Two mAb anti-Id, F25F7 and F25C8, both of the IgM/kappa isotype, were selected for further study. These anti-Id reacted with F23, the mAb for which they were selected, and also reacted with another mAb, which was of the IgG1/kappa isotype and was raised to human MBP peptide 80-89. There was no reaction with another control mAb of the IgG1/kappa isotype or murine myeloma IgG1. By immunoblotting techniques, it was demonstrated that the Id on each of the mAbs to MBP peptides was located on the kappa L chain but also could be recognized in nonreduced IgG. The cross-reactive anti-Id suppressed antibody secretion of Id-producing hybridoma cells in an Id-specific manner, and kinetic studies suggest an intracellular mechanism for the suppression. These cross-reactive Id among antibodies to different MBP peptides imply that the same V region genes of kappa L chains are involved in the selection of antibodies to an autoantigen, like MBP, and may play a role in the modulation of immune responses against MBP in certain inflammatory demyelinating diseases.

This article has been cited by other articles:

				S. ARAGA, L. XU, K. NAKASHIMA, M. VILLAIN, and J. E. BLALOCK A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help FASEB J, January 1, 2000; 14(1): 185 - 196. [Abstract] [Full Text]

				J. N Whitaker Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and neuroimaging changes Multiple Sclerosis, June 1, 1998; 4(3): 243 - 246. [Abstract] [PDF]

				J. N Whitaker Myelin basic protein in cerebrospinal fluid and other body fluids Multiple Sclerosis, February 1, 1998; 4(1): 16 - 21. [Abstract] [PDF]